<DOC>
	<DOC>NCT00109122</DOC>
	<brief_summary>The purpose of this study is to determine the immunity (the body's protection) against shingles after receiving two doses of an investigational vaccine or placebo (a look alike vaccine with no active ingredients).</brief_summary>
	<brief_title>Safety, Tolerability, and the Body's Ability to Develop Resistance to an Investigational Vaccine for Shingles (V211-007)</brief_title>
	<detailed_description>The duration of treatment is 12 weeks.</detailed_description>
	<mesh_term>Herpes Zoster</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Individuals who are at least 60 years of age with a history of varicella (shingles) Females must have been postmenopausal. Subjects who did not previously participate in the main study of this protocol. Subject had shingles since their 6 month followup visit in main phase of study.</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>